연구동향 분석
박사

Influence of Low Pathogenic Escherichia coli on Inflammation, Cell Proliferation, Oxidative Stress, and Angiogenesis in Intestine

이지연 2019년

논문상세정보
인용/피인용
' Influence of Low Pathogenic Escherichia coli on Inflammation, Cell Proliferation, Oxidative Stress, and Angiogenesis in Intestine' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • angiogenesis
  • cell proliferation
  • escherichia coli
  • inflammation
  • intestine
  • low pathogenic intestinal bacteria
  • oxidative stress
  • risk factor
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,905 0

0.0%

' Influence of Low Pathogenic Escherichia coli on Inflammation, Cell Proliferation, Oxidative Stress, and Angiogenesis in Intestine' 의 참고문헌

  • van der Waaij, D., Berghuis-de Vries, J. M., and Lekkerkerk-Van der Wees, J. E. C. 1971. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. Epidemiol. Infect. 69: 405-411.
  • dela Pe a, A., Leclercq, I., Field, J., George, J., Jones, B., and Farrell, G. 2005. NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129: 1663-1674.
  • Zitvogel, L., Galluzzi, L., Viaud, S., V tizou, M., Daill re, R., Merad, M., and Kroemer, G. 2015. Cancer and the gut microbiota: an unexpected link. Sci. Transl. Med. 7: 271ps1-271ps1.
  • Zhang, X., Bai, Q., Xu, L., Kakiyama, G., Pandak Jr, W. M., Zhang, Z., and Ren, S. 2012. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro. Am. J. Physiol.-Gastr. L. 303: G344-G355.
  • Xu, S., Peng, Z., Cui, B., Wang, T., Song, Y., Zhang, L., Wei, G., Wang, Y., and Shen, X. 2014. FliS modulates FlgM activity by acting as a noncanonical chaperone to control late flagellar gene expression, motility and biofilm formation in Yersinia pseudotuberculosis. Environ. Microbiol. 16: 1090-1104.
  • Wu, S., Rhee, K. J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H. R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., Housseau, F., Pardoll, D. M., and Sears, C. L. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15: 1016-1022.
  • Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Ganiats, T. G., Bond, J. H., Rosen, L., Zapka, J. G., Olsen, S. J., Giardiello, F. M., Sisk, J. E., Van Antwerp, R., Brown-Davis, C., Marciniak, D. A., and Mayer, R. J. 1997. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594-642.
  • Weisburger, J. H., Reddy, B. S., Narisawa, T., and Wynder, E. L. 1975. Germ-free status and colon tumor induction by N-methyl-N'-nitro-Nnitrosoguanidine. Proc. Soc. Exp. Biol. Med. 148: 1119-1121.
  • Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808.
  • Wang, S. H., Wang, Y. Z., Zhang, K. Y., Shen, J. H., Zhou, H. Q., and Qiu, X. Y. 2005. Effect of superoxide dismutase and malondialdehyde metabolic changes on carcinogenesis of gastric carcinoma. World J. Gastroenterol. 11:4305-4310.
  • Wang, B., Yao, M., Lv, L., Ling, Z., and Li, L. 2017. The human microbiota in health and disease. Engineering 3: 71-82.
  • Wali, R. K., Khare, S., Tretiakova, M., Cohen, G., Nguyen, L., Hart, J., Wang, J., Wen, M., Ramaswamy, A., Joseph, L., Sitrin, M., Brasitus, T., and Bissonnette, M. 2002. Ursodeoxycholic acid and F6-D3 inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidem. Biomar. 11: 1653-1662.
  • Vowinkel, T., Anthoni, C., Wood, K. C., Stokes, K. Y., Russell, J., Gray, L., Bharwani, S., Senninger, N., Alexander, J. S., Krieglstein, C. F., Grisham, M. B., and Granger, D. N. 2007. CD40–CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology 132: 955-965.
  • Vidal, O., Longin, R., Prigent‐Combaret, C., Dorel, C., Hooreman, M., and Lejeune, P. 1998. Isolation of an Escherichia coli K‐12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J. Bacteriol. 180: 2442-2449.
  • Van Houdt, R., and Michiels, C. W. 2005. Role of bacterial cell surface structures in Escherichia coli biofilm formation. Res. Microbiol. 156: 626-633.
  • Uraz, S., Tahan, G., Aytekin, H., and Tahan, V. 2013. N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats. Scand. J. Clin. Lab. Invest. 73: 61-66.
  • Too, L. K., Ball, H. J., McGregor, I. S., and Hunt, N. H. 2014. The proinflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis. Brain Behav. Immun. 40: 252-268.
  • Terzić, J., Grivennikov, S., Karin, E., and Karin, M. 2010. Inflammation and colon cancer. Gastroenterology 138: 2101-2114.
  • Takahashi, M., Fukuda, K., Sugimura, T., and Wakabayashi, K. 1998. β- Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res. 58: 42-46.
  • Swidsinski, A., Khilkin, M., Kerjaschki, D., Schreiber, S., Ortner, M., Weber, J., and Lochs, H. 1998. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115: 281-286.
  • Stecher, B., and Hardt, W. D. 2008. The role of microbiota in infectious disease. Trends in Microbiol. 16: 107-114.
  • Sperandio, V., Torres, A. G., and Kaper, J. B. 2002. Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two‐component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol. Microbiol. 43: 809-821.
  • Soufli, I., Toumi, R., Rafa, H., and Touil-Boukoffa, C. 2016. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J. Gastrointest Pharmacol. Ther. 7:353-360.
  • Soler, A. P., Miller, R. D., Laughlin, K. V., Carp, N. Z., Klurfeld, D. M., and Mullin, J. M. 1999. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20: 1425-1432.
  • Skrzydlewska, E., Sulkowski, S., Koda, M., Zalewski, B., Kanczuga-Koda, L., and Sulkowska, M. 2005. Lipid peroxidation and antioxidant status in colorectal cancer. World J. Gastroenterol. 11: 403-406.
  • Skrzycki, M., Majewska, M., Podsiad, M., and Czeczot, H. 2009. Expression and activity of superoxide dismutase isoenzymes in colorectal cancer. Acta Biochim. Pol. 56: 663-670.
  • Shirakami, Y., Shimizu, M., Tsurumi, H., Hara, Y., Tanaka, T., and Moriwaki, H. 2008. EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS. Mol. Med. Rep. 1: 355-361.
  • Shin, Y. W., Bae, E. A., Kim, S. S., Lee, Y. C., and Kim, D. H. 2005. Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int. Immunopharmacol. 5: 1183-1191.
  • Serban, D. E. 2014. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett. 345: 258-270.
  • Sears, C. L., Islam, S., Saha, A., Arjumand, M., Alam, N. H., Faruque, A. S. G., Salam, M. A., Shin, J., Hecht, D., Weintraub, A., Sack, R. B., and Qadri, F. 2008. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin. Infect. Dis. 47: 797-803.
  • Sears, C. L., Geis, A. L., and Housseau, F. 2014. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J. Clin. Invest. 124: 4166-4172.
  • Scanlan, P. D., Shanahan, F., Clune, Y., Collins, J. K., O'sullivan, G. C., O'riordan, M., Holmes, E., Wang, Y., and Marchesi, J. R. 2008. Cultureindependent analysis of the gut microbiota in colorectal cancer and polyposis. Environ. Microbiol. 10: 789-798.
  • Sartor, R. B., and Mazmanian, S. K. 2012. Intestinal microbes in inflammatory bowel diseases. Am. J. Gastroenterol. Suppl. 1: 15-21.
  • Robinson, L. S., Ashman, E. M., Hultgren, S. J., and Chapman, M. R. 2006. Secretion of curli fibre subunits is mediated by the outer membranelocalized CsgG protein. Mol. Microbiol. 59: 870-881.
  • Rhee, K. J., Wu, S., Wu, X., Huso, D. L., Karim, B., Franco, A. A., Rabizadeh, S., Golub, J. E., Mathews, L. E., Shin, J., Sartor, R. B., Golenbock, D., Hamad, A. R., Gan, C. M., Housseau, F., and Sears, C. L. 2009. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect. Immun. 77: 1708-1718.
  • R mling, U., Rohde, M., Ols n, A., Normark, S., and Reink ster, J. 2000. AgfD, the checkpoint of multicellular and aggregative behaviour in Salmonella typhimurium regulates at least two independent pathways. Mol. Microbiol. 36: 10-23.
  • Qiu, W., Wu, B., Wang, X., Buchanan, M. E., Regueiro, M. D., Hartman, D. J., Schoen, R. E., Yu, J., and Zhang, L. 2011. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J. Clin. Invest. 121: 1722-1732.
  • Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., Peng, Y., Zhang, D., Jie, Z., Wu, W., Qin, Y., Xue, W., Li, J., Han, L., Lu, D., Wu, P., Dai, Y. Sun, X., Li, Z., Tang, A., Zhong, S., Li, X., Chen, W., Xu, R., Wang, M., Feng, Q., Gong, M., Yu, J., Zhang, Y., Zhang, M., Hansen, T., Sanchez, G., Raes, J., Falony, G., Okuda, S., Almeida, M., LeChatelier, E., Renault, P., Pons, N., Batto, J.-M., Zhang, Z., Chen, H., Yang, R., Zheng, W, Li, S., Yang, H., Wang, J., Ehrlich, S. D., Nielsen, R., Pedersen, O., Kristiansen, K., and Wang, J. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60.
  • Qadri, F., Svennerholm, A.-M., Faruque, A. S. G., and Sack, R. B. 2005. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin. Microbiol. Rev. 18: 465-483.
  • Prigent‐Combaret, C., Prensier, G., Le Thi, T. T., Vidal, O., Lejeune, P., and Dorel, C. 2000. Developmental pathway for biofilm formation in curliproducing Escherichia coli strains: role of flagella, curli and colanic acid. Environ. Microbiol. 2: 450-464.
  • Pfaffl, M. W., Horgan, G. W., and Dempfle, L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30: e36.
  • Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. 1998. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193.
  • Pelucchi, C., Tramacere, I., Boffetta, P., Negri, E., and Vecchia, C. L. 2011. Alcohol consumption and cancer risk. Nutr. Cancer 63: 983-990.
  • Papanikolaou, I., Psilopoulos, D., Ch, L., Lazaris, A., Petraki, K., and Ch, M. 2001. Salmonella colitis or inflammatory bowel disease? A case demonstrating overlapping of clinical, endoscopic and pathologic features. Ann. Gastroenterol. 14: 65-69.
  • O'Mahony, L., Feeney, M., O'Halloran, S., Murphy, L., Kiely, B., Fitzgibbon, J., Lee, G., O'Sullivan, G., Shanahan, F., and Collins, J. K. 2001. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment. Pharmacol. Ther. 15: 1219-1225.
  • O'Hara, A. M., and Shanahan, F. 2006. The gut flora as a forgotten organ. EMBO Rep. 7: 688-693.
  • Nylund, C. M., Goudie, A., Garza, J. M., Fairbrother, G., and Cohen, M. B. 2011. Clostridium difficile infection in hospitalized children in the United States. Arch. Pediatr. Adolesc. Med. 165: 451-457.
  • Nenninger, A. A., Robinson, L. S., Hammer, N. D., Epstein, E. A., Badtke, M. P., Hultgren, S. J., and Chapman, M. R. 2011. CsgE is a curli secretion specificity factor that prevents amyloid fibre aggregation. Mol. Microbiol. 81: 486-499.
  • Nataro, J. P., and Kaper, J. B. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201.
  • Nardi, R. M., Silva, M. E., Vieira, E. C., Bambirra, E. A., and Nicoli, J. R. 1989. Intragastric infection of germfree and conventional mice with Salmonella typhimurium. Braz. J. Med. Biol. Res. 22: 1389-1392.
  • Murray, L. J., Lee, R., and Martens, C. 1990. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse. Eur. J. Immunol. 20: 163-170.
  • Murawaki, Y., Tsuchiya, H., Kanbe, T., Harada, K., Yashima, K., Nozaka, K., Tanida, O., Kohno, M., Mukoyama, T., Nishimuki, E., Kojo, H., Matsura, T., Takahashi, K., Osaki, M., Ito, H., Yodoi, J., Murawaki, Y., and Shiota, G. 2008. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 259: 218-230.
  • Mudter, J., and Neurath, M. F. 2007. IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm. Bowel Dis. 13: 1016-1023.
  • Min, Y. W., and Rhee, P. L. 2015. The role of microbiota on the gut immunology. Clin. Ther. 37: 968-975.
  • McIntosh, G. H. 2008. Influence of selenised dairy proteins on biomarkers of colon cancer risk. Nutr. Diet. 65: S33-S36.
  • Mazagova, M., Wang, L., Anfora, A. T., Wissmueller, M., Lesley, S. A., Miyamoto, Y., Eckmann, L., Dhungana, S., Pathmasiri, W., Sumner, S., Westwater, C., Brenner, D. A., and Schnabi, B. 2014. Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. FASEB J. 29: 1043-1055.
  • Mat s, J. M., and S nchez-Jim nez, F. M. 2000. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell B. 32: 157-170.
  • Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V. D., Sokol, H., Dor , J., Corthier, G., and Furet, J. P. 2009. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9: 123.
  • Mangerich, A., Knutson, C. G., Parry, N. M., Muthupalani, S., Ye, W., Prestwich, E., Cui, L., McFaline, J. L., Mobley, M., Ge, Z., Taghizadeh, K., Wishnok, J. S., Wogan, G. N., Fox, J. G., Tannenbaum, S. R., and Dedon, P. C. 2012. Infection-induced colitis in mice causes dynamic and tissuespecific changes in stress response and DNA damage leading to colon cancer. P. Natl. Acad. Sci. USA. 109: E1820-E1829.
  • Mahowald, M. A., Rey, F. E., Seedorf, H., Turnbaugh, P. J., Fulton, R. S., Wollam, A., Neha, S., Wang, C., Magrini, V., Wilson, R. K., Cantarel, B. L., Coutinho, P. M., Henrissat, B., Crock, L. W., Russell, A., Verberkmoes, N. C., Hettich, R. L., and Gordon, J. I. 2009. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. P. Natl. Acad. Sci. USA. 106: 5859-5864.
  • Maffei, F., Angeloni, C., Malaguti, M., Moraga, J. M. Z., Pasqui, F., Poli, C., Cloecchia, A., Festi, D., Hrelia, P., and Hrelia, S. 2011. Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk. Mutat. Res.-Fund. Mol. M. 714: 88-92.
  • Macnab, R. M. 2004. Type III flagellar protein export and flagellar assembly. Biochim. Biophys. Acta 1694: 207-217.
  • M ller, A. J., Hoffmann, C., Galle, M., Van Den Broeke, A., Heikenwalder, M., Falter, L., Misselwitz, B., Kremer, M., Beyaert, R., and Hardt, W. D. 2009. The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe 6: 125-136.
  • Liu, T., Shi, Y., Du, J., Ge, X., Teng, X., Liu, L., Wang, E., and Zhao, Q. 2016. Vitamin D treatment attenuates 2, 4, 6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis. Sci. Rep. 6: 32889.
  • Liu, R., and Ochman, H. 2007. Stepwise formation of the bacterial flagellar system. P. Natl. A. Sci. USA. 104: 7116-7121.
  • Ley, R. E., Peterson, D. A., and Gordon, J. I. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
  • Lee, H., Shin, N., Song, M., Kang, U. B., Yeom, J., Lee, C., Ahn, Y. H., Yoo, J. S., Paik, Y.-K., and Kim, H. 2010. Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: Clustering with proteins involved in secretion and extranuclear function. J. Proteome Res. 9: 4661-4670.
  • Landini, P. 2009. Cross-talk mechanisms in biofilm formation and responses to environmental and physiological stress in Escherichia coli. Res. Microbiol. 160: 259-266.
  • La Ferla, K., Seegert, D., and Schreiber, S. 2004. Activation of NF-κB in intestinal epithelial cells by E. coli strains isolated from the colonic mucosa of IBD patients. Int. J. Colorectal Dis. 19: 334-342.
  • Kuwano, T., Nakao, S., Yamamoto, H., Tsuneyoshi, M., Yamamoto, T., Kuwano, M., and Ono, M. 2004. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 18: 300-310.
  • Kushida, M., Wanibuchi, H., Wei, M., Kakehashi, A., Ozaki, K., Sukata, T., Miyata, K., Ogata, K., Uwagawa, S., and Fukushima, S. 2009. Ethanol does not promote MeIQx-initiated rat colon carcinogenesis based on evidence from analysis of a colon cancer surrogate marker. J. Toxicol. Pathol. 22: 65-70.
  • Kuppusamy, P., Govindan, N., Yusoff, M. M., and Ichwan, S. J. 2017. Proteins are potent biomarkers to detect colon cancer progression. Saudi J. Biol. Sci. 24: 1212-1221.
  • Kobayashi, T., Glatz, M., Horiuchi, K., Kawasaki, H., Akiyama, H., Kaplan, D. H., Kong, H. H., Amagai, M., and Nagao, K. 2015. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity, 42: 756-766.
  • Kim, S., Keku, T. O., Martin, C., Galanko, J., Woosley, J. T., Schroeder, J. C., Satia, J. A., Halabi, S., and Sandler, R. S. 2008. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res. 68:323-328.
  • Kim, K. A., Gu, W., Lee, I. A., Joh, E. H., and Kim, D. H. 2012. High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway. PloS one 7: e47713.
  • Kaper, J. B., Nataro, J. P., and Mobley, H. L. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2: 123-140.
  • Kamo, N., Ke, B., Ghaffari, A. A., Busuttil, R. W., Cheng, G., and Kupiec‐ Weglinski, J. W. 2013. ASC/caspase‐1/IL‐1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 58: 351-362.
  • Kamiyama, M., Pozzi, A., Yang, L., DeBusk, L. M., Breyer, R. M., and Lin, P. C. 2006. EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene 25: 7019-7028.
  • Jiang, G. L., and Huang, S. 2001. Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res. 61: 1796-1798.
  • Janout, V., and Koll rov , H. 2001. Epidemiology of colorectal cancer. Acta-Universitatis Palackianae Olomucensis Facultatis Medicae, 5-10.
  • Itzkowitz, S. H., and Yio, X. 2004. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol.-Gastrointest. Liver Physiol. 287: G7-G17.
  • IARC (The International Agency for Research on Cancer). 2018. GLOBOCAN 2018: Global and regional estimates of the incidence and mortality for 36 cancers.
  • Houtkooper, R. H., Argmann, C., Houten, S. M., Cant , C., Jeninga, E. H., Andreux, P. A., Thomas, C., Doenlen, R., Schoonjans, K., and Auwerx, J. 2011. The metabolic footprint of aging in mice. Sci. Rep. 1: 134.
  • Housseau, F., and Sears, C. L. 2014. Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis. Cell Cycle 9: 3–5.
  • Hileman, E. O., Liu, J., Albitar, M., Keating, M. J., and Huang, P. 2004. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother. Pharmacol. 53: 209-219.
  • Harmsen, H. J., Raangs, G. C., He, T., Degener, J. E., and Welling, G. W. 2002. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl. Environ. Microb. 68: 2982-2990.
  • Handa, O., Naito, Y., and Yoshikawa, T. 2010. Helicobacter pylori: a ROSinducing bacterial species in the stomach. Inflamm. Res. 59: 997-1003.
  • Hammar, M., Arnqvist, A., Bian, Z., Olsen, A., and Normark, S. 1995. Expression of two csg operons is required for production of fibronectin‐ and congo red‐binding curli polymers in Escherichia coli K‐12. Mol. Microbiol. 18: 661–670.
  • Haggar, F. A., and Boushey, R. P. 2009. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin. Colon Rec. Surg. 22: 191-197.
  • Gu, S., Chen, Y., Zhang, X., Lu, H., Lv, T., Shen, P., Lv, L., Zheng, B., Jiang, X., and Li, L. 2016. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes Infect. 18: 30-38.
  • Grady, W. M., and Carethers, J. M. 2008. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079-1099.
  • Goodwin, A. C., Shields, C. E. D., Wu, S., Huso, D. L., Wu, X., Murray- Stewart, T. R., Hacker-Prietz, A., Rabizadeh, S., Woster, P. M., Sears, C. L., and Casero, R. A. 2011. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. P. Natl. Acad. Sci. USA. 201010203.
  • Gao, R., Gao, Z., Huang, L., and Qin, H. 2017. Gut microbiota and colorectal cancer. Eur. J. Clin. Microbiol. Infect Dis. 36: 757-769.
  • Gagni re, J., Raisch, J., Veziant, J., Barnich, N., Bonnet, R., Buc, E., Bringer, M. A., Pezet, D., and Bonnet, M. 2016. Gut microbiota imbalance and colorectal cancer. World J. Gastroenterol. 22: 501–518.
  • Gaastra, W., and Svennerholm, A. M. 1996. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 4: 444–452.
  • Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo, A., and Tsukita, S. 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1– deficient mice. J. Cell Biol. 156: 1099-1111.
  • Fujii, T., Fuchs, B. C., Yamada, S., Lauwers, G. Y., Kulu, Y., Goodwin, J. M., Lanuti, M., and Tanabe, K. K. 2010. Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. BMC gastroenterol. 10: 79.
  • Erdman, S. E., Sohn, J. J., Rao, V. P., Nambiar, P. R., Ge, Z., Fox, J. G., and Schauer, D. B. 2005. CD4+ CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res. 65: 3998-4004.
  • Emoto, T., Yamashita, T., Sasaki, N., Hirota, Y., Hayashi, T., So, A., Kasahara, K., Yodoi, K., Matsumoto, T., Mizoguchi, T., Ogawa, W., and Hirata K. 2016. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J. Atheroscler. Thromb. 23: 908-921.
  • Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., and Relman, D. A. 2005. Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
  • Dunn, G. P., Ikeda, H., Bruce, A. T., Koebel, C., Uppaluri, R., Bui, J., Chan, R., Diamond, M., White, J. M., Sheehan, K. C., and Schreiber, R. D. 2005. Interferon-γ and cancer immunoediting. Immunol. Res. 32: 231-245.
  • Dong, J., Sulik, K. K., and Chen, S. Y. 2008. Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: Implications for the prevention of fetal alcohol spectrum disorders. Antioxid. Redox Sign. 10: 2023-2033.
  • Devi, G. S., Prasad, M. H., Saraswathi, I., Raghu, D., Rao, D. N., and Reddy, P. P. 2000. Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin. Chim. Acta, 293: 53-62.
  • Darfeuille-Michaud, A., and Colombel, J. F. 2008. Pathogenic Escherichia coli in inflammatory bowel diseases: Proceedings of the 1st International Meeting on E. coli and IBD, June 2007, Lille, France. J. Crohns Colitis 2: 255-262.
  • Cunningham, D., Atkin, W., Lenz, H. J., Lynch, H. T., Minsky, B., Nordlinger, B., and Starling, N. 2010. Colorectal cancer. Lancet 375: 1030-1047.
  • Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., and Finlay, B. B. 2013. Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev. 26: 822-880.
  • Criswell, T. L., and Arteaga, C. L. 2007. Modulation of NFκB activity and E-cadherin by the type III TGFβ receptor regulates cell growth and motility. J. Biol. Chem. 282: 32491-32500.
  • Christofori, G., and Semb, H. 1999. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24: 73-76.
  • Chen, G. Y., Liu, M., Wang, F., Bertin, J., and N ez, G. 2011. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186: 1100412.
  • CDC (Centers for Disease Control and Prevention). 2018. What are the risk factors for colorectal cancer?. Available from: https://www.cdc.gov/cancer/ colorectal/basic_info/risk_factors.htm. Accessed on Oct 15, 2018.
  • Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., and Bonnet, R. 2013. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PloS one 8: e56964.
  • Brown, J. R., and DuBois, R. N. 2005. COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol. 23: 2840-2855.
  • Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., and Jemal, A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 0: 1-31.
  • Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B., and Maisonneuve, P. 2008. Smoking and colorectal cancer: a meta-analysis. JAMA 300: 2765-2778.
  • Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., D chelotte, P., Bonnet, R., Pezet, D., and Darfeuille-Michaud, A. 2014. Colonization of the human gut by E. coli and colorectal cancer risk. Clin. Cancer Res. 20: 859-867.
  • Bonnans, C., Flaceli re, M., Grillet, F., Dantec, C., Desvignes, J. P., Pannequin, J., Severac, D, Dubois, E., Bibeau, F, Escriou, V., Crespy, P, Journot, L., Hollande, F., and Joubert, D. 2012. Essential requirement for β- arrestin2 in mouse intestinal tumors with elevated Wnt signaling. P. Natl. A. Sci. USA. 109: 3047-3052.
  • Bonf , G., Benevides, L., do Carmo Souza, M., Fonseca, D. M., Mineo, T. W. P., Rossi, M. A., Silva, N. M., Silva, J. S., and de Barros Cardoso, C. R. 2014. CCR5 controls immune and metabolic functions during Toxoplasma gondii infection. PloS one 9: e104736.
  • Boleij, A., and Tjalsma, H. 2012. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol. Rev. 87: 701-730.
  • Boleij, A., Hechenbleikner, E. M., Goodwin, A. C., Badani, R., Stein, E. M., Lazarev, M. G., Ellis, B., Carroll, K. C., Albesiano, E., Wick, E. C., Platz, E. A., Pardoll, D. M., and Sears, C. L. 2014. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60: 208-215.
  • Bishehsari, F., Mahdavinia, M., Vacca, M., Malekzadeh, R., and Mariani- Costantini, R. 2014. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J. Gastroenterol. 20: 6055-6072.
  • Bird, R. P. 1995. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93: 55-71.
  • Bioinformatics, Babraham. 2011. FastQC: a quality control tool for high throughput sequence data. Cambridge, UK: Babraham Institute.
  • Bienz, M., and Clevers, H. 2000. Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
  • Berg, D. J., Davidson, N., K hn, R., M ller, W., Menon, S., Holland, G. Thompson-Snipes, L., Leach, M. W., and Rennick, D. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4 (+) TH1-like responses. J. Clin. Invest. 98: 1010-1020.
  • Becker, C., Fantini, M. C., Wirtz, S., Nikolaev, A., Lehr, H. A., Galle, P. R., John, R. and Neurath, M. F. 2005. IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 4: 220-223.
  • Baskar, A. A., Ignacimuthu, S., Paulraj, G. M., and Al Numair, K. S. 2010. Chemopreventive potential of β-sitosterol in experimental colon cancer model-an in vitro and in vivo study. BMC Complem. Altern. M. 10: 24.
  • Bahnassy, A. A., Zekri, A. R. N., El-Houssini, S., El-Shehaby, A. M., Mahmoud, M. R., Abdallah, S., and El-Serafi, M. 2004. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 4: 22.
  • Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., and Bray, F. 2017. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66: 683-691.
  • Anders, S., Pyl, P. T., and Huber, W. 2015. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31: 166-169.
  • American Joint Committee on Cancer (AJCC). 2016. Colon and Rectum. 8th ed. New York: American Joint Committee on Cancer.
  • American Cancer Society. 2017. Colorectal Cancer Facts & Figures 2017- 2019. Atlanta: American Cancer Society.
  • Alexiou, D., Karayiannakis, A. J., Syrigos, K. N., Zbar, A., Kremmyda, A., Bramis, I., and Tsigris, C. 2001. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur. J. Cancer 37: 2392-2397.
  • Aitoro, R., Paparo, L., Amoroso, A., Di Costanzo, M., Cosenza, L., Granata, V., Di Scala, C., Nocerino, R., Trinchese, G., Montella, M., Ercolini, D., and Canani, R. B. 2017. Gut microbiota as a target for preventive and therapeutic intervention against food allergy. Nutrients 9: 672.